Beneficient (BENF) Stock Analysis
Verdict: AVOID
Severe cash burn with under one month of runway and negative equity make BENF an extreme insolvency and dilution trap.
Investment score: 15/100
Analysis as of
Is Beneficient stock worth reviewing? The TradeMates thesis
Beneficient faces acute financial distress characterized by a negative equity balance of -$214.02M, negative current revenues (-$39.13M), and a current ratio of 0.0353. With cash reserves under one month of burn, dilution risk is critical.
7-factor investment score
- Valuation: 10/100 (weight 20%)
- Financial Health: 5/100 (weight 15%)
- Technical Momentum: 15/100 (weight 15%)
- Earnings Quality: 10/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 20/100 (weight 10%)
- Risk-Adjusted Return: 10/100 (weight 15%)
Beneficient opportunities and risks
What speaks for BENF
- Potential digital liquidity platform adoption
What speaks against BENF
- Imminent liquidity depletion and severe dilution
Frequently asked questions about Beneficient (BENF)
Is BENF stock a good investment?
The TradeMates model rates Beneficient as AVOID with an investment score of 15/100. Beneficient faces acute financial distress characterized by a negative equity balance of -$214.02M, negative current revenues (-$39.13M), and a current ratio of 0.0353. With cash reserves under one month of burn, dilution risk is critical. This is algorithmic model output, not personal investment advice.
Is BENF stock a buy?
The TradeMates model verdict for BENF is AVOID with an investment score of 15/100. Treat this as a model signal to review, not a personal buy recommendation.